ITGB4 and cancer: We observed a significant downregulation of ITGB4 in dormant as compared to the proliferating cancer cells in vivo, and in 2-DG-treated as compared to vehicle-treated cancer cells in vitro (Figures 4E, F), while the expression of ITGB1 was unaltered.